Connect with us

International

Cancer drug cooperation could save 1.5 mn lives a year: researchers

Ilustrative image

AFP

Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday.

The figure was based on how long it took two recent cancer drugs to be approved across the world after they were given the green light by the United States.

Pembrolizumab, an effective treatment for most lung cancers, was approved by the US Food and Drug Administration (FDA) in 2016.

More than 600,000 years of patients’ lives could have been saved if Brazil, Canada, China, India, Japan and the European Union had approved the drug at the same time, according to an analysis published in the Harvard Business Review, which is not peer-reviewed.

Advertisement
20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
previous arrow
next arrow

The authors, including US oncologist Bobby Daly, also looked at enzalutamide, which is used to treat prostate cancer.

Enzalutamide was approved by the FDA in 2012, but was not authorised in China for another seven years, partly due to a requirement for separate trials to be carried out there.

The analysis by members of the Bloomberg New Economy International Cancer Coalition found that 284,000 years of patient lives could have been saved if other countries had approved the drug alongside the FDA.

Extrapolating out from their findings, the researchers estimated that if each of the approximately seven cancer drugs approved by the FDA a year were authorised worldwide, it would reduce the number of cancer-related deaths by 10-20 percent. 

That represents roughly 1.5 million of the around 10 million people who die of cancer every year.

Advertisement
20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
previous arrow
next arrow

‘Challenging’ for doctors

“In China alone an estimated 500,000 patient life-years could be saved through harmonisation of trial requirements that have delayed patient access to treatment,” former Australian prime minister Kevin Rudd, co-chair of the Bloomberg cancer coalition, said in a statement.

Mary Gospodarowicz, also a member of the coalition, said that it was “challenging” as an oncologist in Canada when a drug was approved in the US but would take years to be able to prescribe it to her patients. 

The study assumed that the rest of the world had the infrastructure to diagnose and treat cancer as well as the US, which is not always the case, Gospodarowicz told AFP via phone from the World Cancer Congress in Geneva on Tuesday.

But it served as an example of how “removing the barriers to drug approval would be beneficial to patients around the world,” said the former president of the Union for International Cancer Control, which is holding the congress. 

The authors of the analysis called on countries to embrace Project Orbis, a US-led framework aiming to get cancer drugs trialled and approved at the same time in multiple countries.

Advertisement
20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
previous arrow
next arrow

“The US has already made significant progress in setting up the regulatory infrastructure for cancer treatment with the Project Orbis initiative and the task ahead is to take that framework and internationalise it,” former New York mayor Michael Bloomberg said in a statement. 

Continue Reading
Advertisement
20251101_amnistia_mh_cuotas_300x250
20251101_amnistia_mh_sin_multas_300x250
20251101_amnistia_mh_sin_intereses_300x250
20250701_dengue_300x250_01
20250701_dengue_300x250_02
20250901_vacunacion_vsr-300x250
20250901_vacunacion_tetravalente-300x250
20250701_vacunacion-influenza-300x250
20250701_vacunacion_vph-300x250
20250715_donacion_sangre_central_300x250
20231124_etesal_300x250_1
20230601_agenda_primera_infancia_300X250
MARN1

International

Chile enters runoff campaign with Kast leading and Jara seeking a last-minute comeback

Chile’s presidential runoff campaign for the December 14 election kicked off this Sunday, with far-right candidate José Antonio Kast entering the race as the clear favorite in the polls, while left-wing contender Jeannette Jara faces an uphill scenario, hoping for a comeback that some experts describe as “a miracle.”

The final polls released in Chile—published before the mandatory blackout on survey dissemination—give Kast, an ultraconservative former lawmaker running for president for the third time, a lead of between 12 and 16 points. His opponent, the communist former minister in Gabriel Boric’s current administration, is weighed down not only by the government’s low approval ratings but also by a fragmented electorate.

Although Jeannette Jara received the most votes in the first round with 26.9%, her lack of alliances beyond the left makes it difficult for her to expand her support. Kast, who secured 23.9%, has already brought key figures on board: ultralibertarian Johannes Kaiser (13.9%) and traditional right-wing leader Evelyn Matthei (12.4%), both now backing his candidacy.

Analysts note that although Kast’s support base consolidates more than 50% of the electorate, it does not guarantee an automatic transfer of votes. Populist economist Franco Parisi, who placed third with 19.7%, emerges as the major wildcard. His party, the People’s Party (PDG), is set to decide this Sunday through an internal consultation whether to endorse one of the two finalists.

Continue Reading

International

Trump says asylum decision freeze will remain in place “for a long time”

U.S. President Donald Trump warned on Sunday that the suspension of decisions on asylum applications—implemented as part of his order to “halt” immigration from third-world countries following Wednesday’s shooting in Washington—will remain in effect “for a long time.”

The president declined to specify how long the freeze, imposed last Friday by the U.S. Citizenship and Immigration Services (USCIS), would last. The suspension affects individuals waiting for an asylum ruling from that agency, though it does not apply to cases handled by U.S. immigration courts.

The delay is part of a series of measures enacted by the Trump Administration after a shooting on Wednesday in which an Afghan national allegedly opened fire on the National Guard in Washington, D.C., killing one officer and leaving another in critical condition.

Trump has ordered a permanent halt to immigration from 19 countries classified as “third-world.” He also indicated on Sunday that “possibly” more nations could be added to the list.

“These are countries with high crime rates. They are countries that do not function well… that are not known for success, and frankly, we don’t need people from those places coming into our country and telling us what to do,” Trump said, adding: “We don’t want those people.”

Advertisement

20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL

previous arrow
next arrow

USCIS had already announced on Thursday a “rigorous review” of green cards held by migrants from 19 “countries of concern,” including Afghanistan, Cuba, Venezuela, and Haiti.

Continue Reading

International

Sri Lanka and Indonesia deploy military as deadly asian floods kill over 1,000

Sri Lanka and Indonesia deployed military personnel on Monday to assist victims of the devastating floods that have killed more than a thousand people across Asia in recent days.

A series of weather events last week triggered prolonged torrential rains across Sri Lanka, parts of Indonesia’s Sumatra island, southern Thailand, and northern Malaysia. Indonesian President Prabowo Subianto said Monday in North Sumatra that “the priority now is to deliver the necessary aid as quickly as possible.”

“There are several isolated villages that, with God’s help, we will be able to reach,” he added. Subianto also stated that the government had deployed helicopters and aircraft to support relief operations.

Floods and landslides have claimed 502 lives in Indonesia, with a similar number still missing.

This marks the highest death toll from a natural disaster in Indonesia since 2018, when an earthquake and subsequent tsunami killed more than 2,000 people.

Advertisement

20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL

previous arrow
next arrow

The government has sent three military ships carrying aid and two hospital vessels to the hardest-hit regions, where many roads remain impassable.

In the village of Sungai Nyalo, located about 100 kilometers from Padang, the capital of West Sumatra, floodwaters had receded by Sunday, leaving homes, vehicles, and crops coated in thick mud.

Continue Reading

Trending

Central News